Paper41000140
Hemoglobin SC Sickle Cell Disease Presenting as Acute Ischemic Stroke With Moyamoya Syndrome in an Adult: A Case Report.
Nidiginti T and 4 others. Cureus, 2025. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hemoglobin SC Sickle Cell Disease Presenting as Acute Ischemic Stroke With Moyamoya Syndrome in an Adult: A Case Report. Papers, record 41000140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41000140
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hemoglobin SC Sickle Cell Disease Presenting as Acute Ischemic Stroke With Moyamoya Syndrome in an Adult: A Case Report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31276525 | Sickle cell disease complications: Prevalence and resource utilization. | PLoS One | 2019 | https://conductscience.org/library/papers/31276525 | PubMed |
| 2 | 38024048 | Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. | Cureus | 2023 | https://conductscience.org/library/papers/38024048 | PubMed |
| 3 | 7993409 | Mortality in sickle cell disease. Life expectancy and risk factors for early death. | N Engl J Med | 1994 | https://conductscience.org/library/papers/7993409 | PubMed |
| 4 | 36937514 | Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis. | Front Neurol | 2023 | https://conductscience.org/library/papers/36937514 | PubMed |
| 5 | 37082003 | Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives. | J Blood Med | 2023 | https://conductscience.org/library/papers/37082003 | PubMed |
| 6 | 9414296 | Cerebrovascular accidents in sickle cell disease: rates and risk factors. | Blood | 1998 | https://conductscience.org/library/papers/9414296 | PubMed |
| 7 | 19297575 | Moyamoya disease and moyamoya syndrome. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19297575 | PubMed |
| 8 | 15703904 | TCD in sickle cell disease: an important and useful test. | Pediatr Radiol | 2005 | https://conductscience.org/library/papers/15703904 | PubMed |
| 9 | 22315500 | Hemoglobin sickle cell disease complications: a clinical study of 179 cases. | Haematologica | 2012 | https://conductscience.org/library/papers/22315500 | PubMed |
| 10 | 19205968 | Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. | Hemoglobin | 2009 | https://conductscience.org/library/papers/19205968 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41000140
GET https://conductscience.org/api/papers/v1/41000140/authors